In early glimpse at data, Akili’s video game shows positive results with adults with ADHD

Akili Interactive on Wednesday revealed earlier-than-expected top-line clinical trial results suggesting its video game treatment for attention deficit hyperactivity disorder is effective for adults.

That’s very good news for a company that’s racing to reach more patients in hopes of building a sustainable business.

Akili’s treatment, EndeavorRx, is a mobile device game set in space that’s specially designed to target attention and related cognitive functions. In 2020, the game was cleared by the Food and Drug Administration to treat ADHD in children ages 8 to 12, but Akili had always planned to target other populations. The new glimpse at the adult pivotal trial results follow positive data the company released earlier this year in a trial testing EndeavorRx with adolescents ages 13 to 17.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In